Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

  • When typing in this field, a list of search results will appear and be automatically updated as you type.

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

dayzz announces the publication of a unique, remote clinical trial design to improve employees' sleep, health, productivity, and safety


News provided by

dayzz

11 Jan, 2022, 16:00 IST

Share this article

Share toX

Share this article

Share toX

BOSTON, Jan. 11, 2022 /PRNewswire/ -- dayzz, an AI-based digital sleep health solution, has recently supported the launch of a research study evaluating a personalized sleep training program delivered by the dayzz' smartphone app. The study investigates the impact of this mobile health platform for identifying and treating sleep disorders within a large organization. The study was conducted at Brigham and Women's Hospital (Boston, MA). The study protocol, published online in the peer-reviewed journal PLOS ONE, describes the patient-centered clinical trial, which was conducted completely remotely, allowing for large-scale recruitment and broader participant diversity.

"Sleep problems are highly prevalent but often underdiagnosed," says Charles A. Czeisler, MD, PhD, FRCP, Chief of the Division of Sleep and Circadian Disorders at Brigham and Women's Hospital and Director of the Division of Sleep Medicine at Harvard Medical School, who led the study. "The emergence of the COVID-19 pandemic has evidenced even higher rates of sleep problems among the general population, and particularly healthcare workers." 

The sleep intervention is conducted using the dayzz' digital app platform, providing employees with personalized sleep treatment plans, contextual nudges, sleep management tools, and a clinically validated sleep assessment. For identified participants at risk for sleep apnea, the remote trial includes an in-app digital referral to Brigham's Sleep Clinic for a telemedicine consultation and home sleep testing, enabling comprehensive end-to-end wellness and a medically guided journey.

"Given the increase in sleep and fatigue-related workplace disturbances and associated productivity, medical and safety costs, an urgency has been arising among organizations to find proven, accessible, and scalable solutions to remotely evaluate and treat sleep among their workers,'' says dayzz' Chief Science Officer, Dr. Mairav Cohen-Zion. "This study aims to measure the impact of sleep improvement on financial and medical KPIs in an employee population within a large organization."

More about dayzz:

dayzz is an innovative digital sleep solution, providing personalized sleep training plans to individuals across the US. dayzz' machine learning engine enables assessment of common sleep problems. Based on big data analysis, the app constantly adjusts users' training plans to fit their needs and progress, and offers the right intervention at the right time, with continuous support and unique motivational strategies. dayzz offers its sleep solution to US employers and payers to increase productivity, enhance well-being, optimize usage of the healthcare system and reduce associated costs. Based on the vast amounts of data gathered, employers receive periodic overview reports, presenting aggregated data about their employees' sleep status to help them better understand how to further improve employee experience and performance. The company is led by an experienced team in the fields of business, technology, and clinical treatment. For more information, visit https://dayzz.com.

Media Contact

Sydney Dennen
Account Manager
ReBlonde, Tel Aviv, Israel
[email protected]

SOURCE dayzz

Modal title

Contact PR Newswire

  • +972-77-2005042
    from 8 AM - 11 PM IL

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Csezh
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italie
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+972-77-2005042
from 8 AM - 11 PM IL
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.